Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-19 11:52 am Purchase | 2021-02-09 | 13G | ADARA ACQUISITION CORP UNIT 1 ADRAU | CVI Investments, Inc. | 500,000 5.000% | 500,000 (New Position) | Filing History |
| 2021-02-19 11:44 am Purchase | 2021-02-09 | 13G | enVVeno Medical Corporation NVNO | CVI Investments, Inc. | 435,714 5.600% | 435,714 (New Position) | Filing History |
| 2021-02-19 11:43 am Purchase | 2021-02-11 | 13G | Cyren Ltd. CYRN | CVI Investments, Inc. | 225,000 6.000% | 225,000 (New Position) | Filing History |
| 2021-02-19 11:38 am Purchase | 2021-02-10 | 13G | Staffing 360 Solutions, Inc. STAF | CVI Investments, Inc. | 3,750 5.900% | 3,750 (New Position) | Filing |
| 2021-02-19 10:46 am Purchase | 2021-02-10 | 13G | Neovasc Inc. NVCN | CVI Investments, Inc. | 160,000 6.100% | 160,000 (New Position) | Filing History |
| 2021-02-16 10:09 am Sale | 2020-12-31 | 13G | U.S. Energy Corp. USEG | CVI Investments, Inc. | 50,000 1.700% | -180,000 (-78.26%) | Filing History |
| 2021-02-16 10:09 am Sale | 2020-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | CVI Investments, Inc. | 0 0.100% | -2 (-91.05%) | Filing History |
| 2021-02-16 10:08 am Purchase | 2020-12-31 | 13G | Tilray Brands, Inc. TLRY | CVI Investments, Inc. | 5,877,517 4.900% | 5,877,517 (New Position) | Filing History |
| 2021-02-16 10:08 am Sale | 2020-12-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | CVI Investments, Inc. | 315,249 2.700% | -259,135 (-45.12%) | Filing History |
| 2021-02-16 10:07 am Unchanged | 2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | CVI Investments, Inc. | 4,022 4.100% | 0 (Unchanged) | Filing History |
| 2021-02-16 10:06 am Purchase | 2021-12-31 | 13G | ReWalk Robotics Ltd. LFWD | CVI Investments, Inc. | 92,585 2.600% | 92,585 (New Position) | Filing History |
| 2021-02-16 10:06 am Sale | 2020-12-31 | 13G | Rockwell Medical, Inc. RMTI | CVI Investments, Inc. | 446,776 4.900% | -95,066 (-17.55%) | Filing History |
| 2021-02-16 10:05 am Purchase | 2020-12-31 | 13G | Recon Technology, Ltd. RCON | CVI Investments, Inc. | 21,017 4.900% | 21,017 (New Position) | Filing History |
| 2021-02-16 10:05 am Purchase | 2020-12-31 | 13G | Pulmatrix, Inc. PULM | CVI Investments, Inc. | 90,355 4.900% | 22,855 (+33.86%) | Filing History |
| 2021-02-16 10:04 am Purchase | 2020-12-31 | 13G | Purple Biotech Ltd. PPBT | CVI Investments, Inc. | 67,444 0.800% | 67,444 (New Position) | Filing History |
| 2021-02-16 10:03 am Sale | 2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | CVI Investments, Inc. | 2,119 4.000% | -1,846 (-46.55%) | Filing History |
| 2021-02-16 10:03 am Purchase | 2020-12-31 | 13G | Alto Ingredients, Inc. ALTO | CVI Investments, Inc. | 3,798,329 4.900% | 3,798,329 (New Position) | Filing History |
| 2021-02-16 10:02 am Purchase | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | CVI Investments, Inc. | 40,748 4.800% | 22,462 (+122.84%) | Filing History |
| 2021-02-16 10:01 am Purchase | 2020-12-31 | 13G | Intec Pharma Ltd NTEC | CVI Investments, Inc. | 23,750 2.400% | 23,750 (New Position) | Filing History |
| 2021-02-16 10:01 am Purchase | 2020-12-31 | 13G | Myomo, Inc. MYO | CVI Investments, Inc. | 240,639 4.900% | 15,005 (+6.65%) | Filing History |